Allurion Technologies Inc (ALUR)
1.86
-0.06
(-3.12%)
USD |
NYSE |
May 16, 16:00
1.88
+0.02
(+1.08%)
Pre-Market: 20:00
Allurion Technologies Cash from Financing (Quarterly): -20.41M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -20.41M |
September 30, 2023 | 98.89M |
June 30, 2023 | 4.641M |
March 31, 2023 | 12.87M |
Date | Value |
---|---|
December 31, 2022 | 14.64M |
September 30, 2022 | 9.788M |
June 30, 2022 | 4.943M |
March 31, 2022 | 1.166M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-20.41M
Minimum
Dec 2023
98.89M
Maximum
Sep 2023
15.82M
Average
7.366M
Median
Cash from Financing (Quarterly) Benchmarks
Outset Medical Inc | 68.61M |
Paragon 28 Inc | -1.262M |
Perspective Therapeutics Inc | 0.352M |
Xtant Medical Holdings Inc | 0.325M |
Asensus Surgical Inc | 0.811M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -20.87M |
Cash from Investing (Quarterly) | -0.398M |
Free Cash Flow | -65.59M |
Free Cash Flow Per Share (Quarterly) | -0.4463 |
Free Cash Flow to Equity (Quarterly) | -2.235M |
Free Cash Flow to Firm (Quarterly) | -18.00M |
Free Cash Flow Yield | -77.93% |